Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
about
EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with AktLoss of protein inhibitors of activated STAT-3 expression in glioblastoma multiforme tumors: implications for STAT-3 activation and gene expressionIdentification of a PTEN-regulated STAT3 brain tumor suppressor pathwayExpression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine modelLRRC4, a putative tumor suppressor gene, requires a functional leucine-rich repeat cassette domain to inhibit proliferation of glioma cells in vitro by modulating the extracellular signal-regulated kinase/protein kinase B/nuclear factor-kappaB pathwA phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668].Molecular characterizations of glioblastoma, targeted therapy, and clinical results to dateThe role of NF-κB in the pathogenesis of gliomaInfluence of caloric restriction on constitutive expression of NF-κB in an experimental mouse astrocytomaCoactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapiesEarly termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adultsGenetics of glioblastoma: a window into its imaging and histopathologic variability.Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growthDehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ.Constitutive activation of signal transducer and activator of transcription 3 regulates expression of vascular endothelial growth factor in human meningioma differentiation.Nuclear factor IA is expressed in astrocytomas and is associated with improved survival.Transcriptional regulation of adrenomedullin by oncostatin M in human astroglioma cells: implications for tumor invasion and migrationMutational analysis reveals the origin and therapy-driven evolution of recurrent gliomaSulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB.Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in (12) V-Ha-Ras transgenic mouse glioma model.Identification of differential splicing genes in gliomas using exon expression profiling.Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of β-Catenin.Growth inhibitory in vitro effects of glycyrrhizic acid in U251 glioblastoma cell line.NF-κB addiction and its role in cancer: 'one size does not fit all'.Astrocyte elevated gene-1: a novel target for human glioma therapy.MicroRNA-146a inhibits glioma development by targeting Notch1Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity.Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastomaEndogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapyInsulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB networkIdentification of a novel pro-apopotic function of NF-kappaB in the DNA damage response.The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas.Emerging insights into the molecular and cellular basis of glioblastoma.Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors.MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma.Phosphoproteomics for oncology discovery and treatment.Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastomaDeletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients.
P2860
Q24310260-AD85CFCF-D869-4BF5-94BC-FE163A7947FFQ24619748-8A8AF451-C8F3-46C7-9579-FE1D01279A2CQ24650927-E7E12808-067C-4DF3-A854-BE2CAC138E6FQ24656542-5E9C1414-EC02-46FD-A2A6-B22D58C21396Q24685269-71029483-01B3-4502-8FB9-C92B080E817DQ25257862-D52027F9-2F3E-46F6-B6E8-8100F2A0F8C3Q26822717-57C399C8-F92A-4AA5-99A8-8A1AB88F2346Q26825502-FFA0D33E-DCBB-4227-A21E-E5DC5EE44671Q28477560-74465BDE-75A6-456B-87D7-4A8292DB3590Q29615606-D187EE36-AE0B-4AAE-B7A5-4D870EA298FEQ33511367-87F03A14-9509-46E6-BC9A-5A93095054ADQ33620506-3D65C6C6-F9BC-41EB-81EC-2FC8FD2D39F7Q33674790-DE353182-A1BC-4904-9A90-9682CF1C2949Q33850038-9F414548-A4DB-474C-95CF-FFAF72088582Q33868792-5FF6A7D3-5C6B-42DB-9A53-4B9D85AAD030Q34132748-D33FC22B-C124-4DC1-9E5B-84FADE144E0AQ34228086-E3926345-78E9-4138-99ED-1171789FD42BQ34391844-F0A11FFE-A01F-422D-92D8-28DA5B64728AQ34543666-96DB4B5C-1F38-4499-95E4-CA3B642F5963Q34568628-7127E644-08EC-42D0-8E9E-83DDF13A1796Q34673613-733E6E2E-8E66-410C-8F9E-149AC13298C5Q34797694-51824EE9-ACBC-48E3-A7EF-9BAA7EC567E6Q35090839-A6D7108B-E2D7-477F-B8A4-89723A0A8577Q35120893-85135B27-F815-42BC-B6FA-35AC06E01A0BQ35190515-E9DEF7AB-1F6D-41C0-94B3-756049B800DCQ35192143-2956F4E1-18A2-4757-ACE5-D3631365FC99Q35212521-13805B48-ACB0-4A71-8675-223FA9D78C4FQ35440540-61DA9237-7F4E-427F-A962-1CE508051FCCQ35781926-AA3435C8-CE27-4CC4-AAB6-6D38E799EC57Q35800124-DC3A3240-0718-4E48-9013-E7B925B36A1CQ35800448-8E102A9D-4A07-4B6E-8E18-1EB16151B470Q35807732-56571FB6-C82D-45AF-8644-1340C9BC64DFQ35832054-2386DD02-5B82-43FC-A8F1-64BE6E467894Q35864082-8B5990B4-BA66-42BB-BC5B-23E98E98A3E1Q35914897-1403E6B7-3E63-4B50-BA8B-75B939F2A3D0Q35927501-80053686-D1C1-4EEA-8935-193E95F41F40Q36139783-912F767A-7F6C-4ABF-A61C-B8AE9DBE010AQ36219744-D28C51D1-CF8B-4755-9E95-629B5639B01DQ36232178-631DC26A-558E-44F5-8416-CB5FA1A18653Q36774118-7365E752-CDE8-4BBB-AA5A-08A727A3C2D0
P2860
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
@en
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
@nl
type
label
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
@en
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
@nl
prefLabel
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
@en
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
@nl
P2093
P2860
P1476
Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.
@en
P2093
Helen J Huang
Huamin Wang
Warren S L Liao
P2860
P2888
P304
P356
10.1038/LABINVEST.3700123
P577
2004-08-01T00:00:00Z